EBV LMP2A 抗体
Quick Overview for EBV LMP2A 抗体 (ABIN2473474)
抗原
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
产品特性
- Purified IgG
-
纯化方法
- Purified
-
免疫原
- Bacterial TrpE-LMP2A fusion protein
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1.0 mg/mL
-
-
-
: "Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation." in: Journal of neuropathology and experimental neurology, Vol. 69, Issue 7, pp. 677-93, (2010) (PubMed).
: "Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22." in: Neoplasia (New York, N.Y.), Vol. 11, Issue 11, pp. 1174-84, (2009) (PubMed).
-
: "Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation." in: Journal of neuropathology and experimental neurology, Vol. 69, Issue 7, pp. 677-93, (2010) (PubMed).
-
- EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
-
别名
- EPSTEIN-BARR VIRUS LMP2A
-
物质类
- Viral Protein
-
背景
- Synonyms: EBV
抗原
-